Access cutting-edge essential thrombocythemia treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Detroit location
Access essential thrombocythemia specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related essential thrombocythemia treatment provided free
Check if you qualify for this essential thrombocythemia clinical trial in Detroit, MI
No-Cost Study Care
Local to Detroit
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a study evaluating the safety and efficacy of bomedemstat (MK-3543) compared with the best available therapy (BAT) in participants with essential thrombocythemia (ET) who have an inadequate response to or are intolerant of hydroxyurea. The primary study hypothesis is that bomedemstat is superior to the best available therapy with respect to durable clinicohematologic response (DCHR).
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT06079879) has an active research site in Detroit, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for essential thrombocythemia treatment options in Detroit, MI, this clinical trial (NCT06079879) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced essential thrombocythemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all essential thrombocythemia clinical trials near you to find additional studies recruiting in your area.
See all myeloproliferative neoplasms clinical trials recruiting in Detroit — not just this study.
Browse Myeloproliferative Neoplasms Trials in Detroit →